1. Home
  2. VSH vs LGND Comparison

VSH vs LGND Comparison

Compare VSH & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSH
  • LGND
  • Stock Information
  • Founded
  • VSH 1962
  • LGND 1987
  • Country
  • VSH United States
  • LGND United States
  • Employees
  • VSH N/A
  • LGND N/A
  • Industry
  • VSH Electrical Products
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSH Technology
  • LGND Health Care
  • Exchange
  • VSH Nasdaq
  • LGND Nasdaq
  • Market Cap
  • VSH 2.3B
  • LGND 2.3B
  • IPO Year
  • VSH N/A
  • LGND 1992
  • Fundamental
  • Price
  • VSH $17.46
  • LGND $109.19
  • Analyst Decision
  • VSH Buy
  • LGND Strong Buy
  • Analyst Count
  • VSH 3
  • LGND 6
  • Target Price
  • VSH $22.00
  • LGND $145.00
  • AVG Volume (30 Days)
  • VSH 3.0M
  • LGND 127.1K
  • Earning Date
  • VSH 02-05-2025
  • LGND 02-25-2025
  • Dividend Yield
  • VSH 2.30%
  • LGND N/A
  • EPS Growth
  • VSH N/A
  • LGND 160.46
  • EPS
  • VSH 0.62
  • LGND 2.47
  • Revenue
  • VSH $3,008,107,000.00
  • LGND $152,422,000.00
  • Revenue This Year
  • VSH N/A
  • LGND $26.86
  • Revenue Next Year
  • VSH $4.61
  • LGND $14.54
  • P/E Ratio
  • VSH $28.05
  • LGND $44.04
  • Revenue Growth
  • VSH N/A
  • LGND N/A
  • 52 Week Low
  • VSH $14.95
  • LGND $67.53
  • 52 Week High
  • VSH $24.69
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • VSH 48.53
  • LGND 40.09
  • Support Level
  • VSH $16.81
  • LGND $111.98
  • Resistance Level
  • VSH $17.87
  • LGND $117.54
  • Average True Range (ATR)
  • VSH 0.71
  • LGND 5.61
  • MACD
  • VSH -0.05
  • LGND -1.15
  • Stochastic Oscillator
  • VSH 31.86
  • LGND 5.78

About VSH Vishay Intertechnology Inc.

Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer worldwide. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: